Track market-moving stories before they get noisy

Advancing transparency and responsible journal evaluation

, /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the release of the Journal Citation Reports 2026. Now in its sixth decade, Journal Citation Reports (JCR) continues to provide a publisher-neutral framework for assessing journal influence across the global research ecosystem.

The 2026 edition builds on a series of recent enhancements designed to improve consistency, transparency and inclusivity in journal-level metrics. It includes metrics for 22,643 journals across 254 categories, reflecting the breadth and diversity of scholarly publishing worldwide.

Bar Veinstein, President, Academia & Government at Clarivate, said: "As scholarly publishing continues to evolve, we remain focused on helping publishers, librarians and researchers make informed decisions with confidence. The Journal Citation Reports 2026 reflects our ongoing commitment to supporting the research community with trusted, transparent and context-rich journal intelligence.

"Our publisher-neutral approach, ongoing refinements and focus on research integrity means that JCR continues to serve as a gold-standard benchmark for the global scholarly community, over fifty years after its first publication."

New data highlights growing diversification of research

The 2026 release, reflecting 2025 data, highlights several notable trends shaping scholarly publishing:

Expansion of global participation: 521 journals received a Journal Impact Factor for the first time, from 47 countries/regions. Of these journals, 58% are based outside the United States and Western EuropeShifts in author geography: Mainland China and the United States remain the most represented countries/regions, accounting for 48% of author affiliationsGlobal South representation continues to grow. The countries/regions with the largest increases in author representation from 2023 to 2025 are Mainland China (23%) and India (12%)Global South author affiliations increased 6% from 2024 and 10% from 2023.These trends underscore the increasing globalization and diversification of research output.

Supporting responsible use of journal metrics

To support more balanced and contextual interpretation, the JCR provides a range of complementary indicators beyond the Journal Impact Factor, including field-normalized metrics such as the Journal Citation Indicator (JCI), descriptive data and category-level benchmarks. The journal-level indicators contained within the JCR are designed to support journal evaluation, not to assess the performance of individual researchers or articles.

This multidimensional approach enables publishers, librarians and researchers to interpret journal performance within the appropriate disciplinary and methodological context, supporting more informed decision-making.

A consistent and trusted foundation for the global research community

Consistency remains a defining strength of Journal Citation Reports. Stable methodology and dependable year-on-year data enable stakeholders to:

Evaluate journal performanceSupport collection and funding decisionsInterpret trends across disciplines over time. Learn more about the Journal Citation Reports 2026 release.

Notes to editors:

About Clarivate
Clarivate is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com

Media contact:
Amy Bourke-Waite, Senior Director External Communications
[email protected]

View original content to download multimedia:https://www.prnewswire.com/news-releases/clarivate-releases-journal-citation-reports-2026-302802576.html

SOURCE Clarivate Plc

Twilio (TWLO - Free Report) closed the most recent trading day at $186.17, moving -1.03% from the previous trading session. This change lagged the S&P 500's daily gain of 1.09%. Meanwhile, the Dow experienced a rise of 0.14%, and the technology-dominated Nasdaq saw an increase of 1.91%.

The company's shares have seen a decrease of 0.64% over the last month, not keeping up with the Computer and Technology sector's gain of 0.22% and the S&P 500's gain of 0.29%.

Investors will be eagerly watching for the performance of Twilio in its upcoming earnings disclosure. It is anticipated that the company will report an EPS of $1.31, marking a 10.08% rise compared to the same quarter of the previous year. Meanwhile, our latest consensus estimate is calling for revenue of $1.42 billion, up 15.84% from the prior-year quarter.

In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $5.63 per share and a revenue of $5.81 billion, indicating changes of +15.13% and +14.61%, respectively, from the former year.

Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Twilio. Recent revisions tend to reflect the latest near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.

Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.

Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Twilio is currently sporting a Zacks Rank of #3 (Hold).

In the context of valuation, Twilio is at present trading with a Forward P/E ratio of 33.44. This signifies a premium in comparison to the average Forward P/E of 18.05 for its industry.

We can additionally observe that TWLO currently boasts a PEG ratio of 1.86. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. TWLO's industry had an average PEG ratio of 1 as of yesterday's close.

The Internet - Software industry is part of the Computer and Technology sector. This industry currently has a Zacks Industry Rank of 84, which puts it in the top 35% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.

TORONTO, June 16, 2026 (GLOBE NEWSWIRE) -- Fairfax Financial Holdings Limited (TSX: FFH and FFH.U) (“Fairfax”) announced today that the previously announced acquisition of Kennedy-Wilson Holdings, Inc. (“Kennedy Wilson”) by an entity affiliated with a consortium (the “Consortium”) led by William McMorrow, Chairman and Chief Executive Officer of Kennedy Wilson, certain other senior executives of the Company (collectively, the “KW Management Group”), and certain affiliates of Fairfax for US$10.90 per share in cash pursuant to a Merger Agreement has been completed. The KW Management Group, led by William McMorrow, has effective and operational control of and continues to lead and have ultimate responsibility for Kennedy Wilson and its subsidiaries while Fairfax holds a majority of the economic interest.

In addition, an affiliate of the Consortium (the “Borrower”) entered into a Term Loan Credit Agreement (the “Credit Agreement”) pursuant to which it obtained a three-year US$1.3 billion term loan facility. In connection with the Credit Agreement, Fairfax agreed to provide a stand-by guarantee pursuant to which Fairfax would agree, upon the occurrence of certain events under the Credit Agreement, to guarantee in favour of the lenders the obligations of the Borrower under the Credit Agreement.

About Fairfax

Fairfax Financial Holdings Limited is a holding company which, through its subsidiaries, is primarily engaged in property and casualty insurance and reinsurance and the associated investment management.

Fairfax Financial Holdings Limited’s head and registered office is located at 95 Wellington Street West, Suite 800, Toronto, Ontario, M5J 2N7.

For further information, contact:John Varnell, Vice President, Corporate Development at (416) 367-4941
Certain statements contained herein may constitute “forward-looking statements” and are made pursuant to the “safe harbour” provisions of applicable Canadian and U.S. securities laws. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Fairfax to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, but are not limited to: our ability to complete acquisitions and other strategic transactions on the terms and timeframes contemplated, and to achieve the anticipated benefits therefrom; a reduction in net earnings if our loss reserves are insufficient; underwriting losses on the risks we insure that are higher than expected; the occurrence of catastrophic events with a frequency or severity exceeding our estimates; changes in market variables, including unfavourable changes in interest rates, foreign exchange rates, equity prices and credit spreads, which could negatively affect our operating results and investment portfolio; the cycles of the insurance market and general economic conditions, which can substantially influence our and our competitors’ premium rates and capacity to write new business; insufficient reserves for asbestos, environmental and other latent claims; exposure to credit risk in the event our reinsurers fail to make payments to us under our reinsurance arrangements; exposure to credit risk in the event our insureds, insurance producers or reinsurance intermediaries fail to remit premiums that are owed to us or failure by our insureds to reimburse us for deductibles that are paid by us on their behalf; our inability to maintain our long term debt ratings, the inability of our subsidiaries to maintain financial or claims paying ability ratings and the impact of a downgrade of such ratings on derivative transactions that we or our subsidiaries have entered into; risks associated with implementing our business strategies; the timing of claims payments being sooner or the receipt of reinsurance recoverables being later than anticipated by us; risks associated with any use we may make of derivative instruments; the failure of any hedging methods we may employ to achieve their desired risk management objective; a decrease in the level of demand for insurance or reinsurance products, or increased competition in the insurance industry; the impact of emerging claim and coverage issues or the failure of any of the loss limitation methods we employ; our inability to access cash of our subsidiaries; an increase in the amount of capital that we and our subsidiaries are required to maintain and our inability to obtain required levels of capital on favourable terms, if at all; the loss of key employees; our inability to obtain reinsurance coverage in sufficient amounts, at reasonable prices or on terms that adequately protect us; the passage of legislation subjecting our businesses to additional adverse requirements, supervision or regulation, including additional tax regulation, in the United States, Bermuda, Canada or other jurisdictions in which we operate; risks associated with applicable laws and regulations relating to sanctions, anti-money laundering and corrupt practices in Canada and in foreign jurisdictions in which we operate; risks associated with government investigations of, and litigation and negative publicity related to, insurance industry practice or any other conduct; risks associated with political and other developments in foreign jurisdictions in which we operate; risks associated with legal or regulatory proceedings or significant litigation; failures or security breaches of our computer and data processing systems; the influence exercisable by our significant shareholder; adverse fluctuations in foreign currency exchange rates; our dependence on independent brokers over whom we exercise little control; financial reporting risks relating to deferred taxes associated with amendments to IAS 12 – Income Taxes; impairment of the carrying value of our goodwill, indefinite-lived intangible assets or investments in associates; our failure to realize deferred income tax assets; risks associated with Canadian or foreign tax laws, or the interpretation thereof; technological or other change that adversely impacts demand, or the premiums payable, for the insurance coverages we offer; disruptions of our information technology systems; assessments and shared market mechanisms that may adversely affect our insurance subsidiaries; risks associated with economic disruptions from global conflicts and the development of other geopolitical events worldwide; and risks associated with tariffs, trade restrictions, or other regulatory measures imposed by domestic or foreign governments that may, directly or indirectly, affect our business. Additional risks and uncertainties are described in our most recently issued Annual Report which is available at www.fairfax.ca and on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov, and in our base shelf prospectus (under “Risk Factors”) filed with the securities regulatory authorities in Canada, which is available on SEDAR+ at www.sedarplus.ca. Fairfax disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities law.

BEVERLY HILLS, Calif.--(BUSINESS WIRE)--Kennedy-Wilson, Inc. (the “Issuer”), a wholly-owned subsidiary of global real estate investment company Kennedy-Wilson Holdings, Inc. (the “Company” or “Kennedy Wilson”), today announced the expiration and results of its previously announced offer to purchase for cash (the “Offer”) any and all of its outstanding 5.000% Senior Notes due 2031 (the “Notes”), upon the terms and subject to the conditions set forth in the Offer to Purchase, dated May 15, 2026 (the “Offer to Purchase”). The Offer was made pursuant to the Fundamental Change Offer provisions of the indenture governing the Notes (the “Indenture”) in connection with the acquisition of the Company pursuant to an Agreement and Plan of Merger (the “Merger Agreement”), dated as of February 16, 2026, as amended on March 15, 2026, by and among the Company, Kona Bidco, LLC and Kona Merger Subsidiary, Inc. (“Merger Sub”), an entity affiliated with a consortium led by William McMorrow, Chairman and Chief Executive Officer of the Company, and certain other senior executives of the Company, and including Fairfax Financial Holdings Limited (“Fairfax”) (collectively, the “Consortium”), pursuant to which Merger Sub merged with and into the Company, and the Company continued as the surviving corporation (the “Merger”). The consummation of the Merger constituted a Fundamental Change under the Indenture.

The Offer expired at 5:00 p.m., New York City time, on June 15, 2026 (the “Expiration Time”). According to information provided by D.F. King & Co., Inc., as tender and information agent for the Offer (the “Tender and Information Agent”), $594,152,000 aggregate principal amount of Notes, representing 99.03% of the $600,000,000 aggregate principal amount of the Notes outstanding as of the date of the Offer to Purchase, were validly tendered and not validly withdrawn at or prior to the Expiration Time.

The Issuer has accepted for purchase all Notes validly tendered and not validly withdrawn at or prior to the Expiration Time. The table below sets forth information about the Notes:

Issuer

Title of Security

CUSIP No.

Aggregate Principal Amount Outstanding

Aggregate Principal Amount Tendered and Accepted for Purchase

Purchase Price (per $1,000 principal amount) (1)

Accrued Interest

Kennedy-Wilson, Inc.

5.000% Senior Notes due 2031

489399AM7

$600,000,000

$594,152,000

$1,010.00 (101.000% of principal amount)

Accrued and unpaid interest to, but excluding, the Purchase Date

Payment for Notes validly tendered and not validly withdrawn and accepted for purchase was made on June 16, 2026 (the “Purchase Date”), in immediately available funds through the Tender and Information Agent and The Depository Trust Company (“DTC”). Following the purchase and cancellation of the Notes accepted for purchase pursuant to the Offer, $5,848,000 aggregate principal amount of Notes remain outstanding.

No Consent Solicitation

The Offer was not being made in connection with any consent solicitation, and Kennedy Wilson did not seek any amendment, waiver or modification of the Indenture governing the Notes in connection with the Offer. Notes not tendered and purchased in the Offer will remain outstanding and will continue to be governed by the existing terms of the Indenture.

Tender and Information Agent

D.F. King & Co., Inc. was appointed as tender and information agent for the Offer. Questions concerning the Offer may be directed to the Tender and Information Agent by phone (toll-free) at (877) 297-1746 or (all other calls) at (212) 256-9073, or by email at [email protected].

Offer Disclaimer

This press release is for informational purposes only and does not constitute an offer to purchase or a solicitation of an offer to sell the Notes. The Offer was made only pursuant to the Offer to Purchase and the related materials. The complete terms and conditions of the Offer are described in the Offer to Purchase, copies of which may be obtained by contacting the Tender and Information Agent using the contact information set forth above.

About Kennedy Wilson

Kennedy Wilson is a leading real estate investment company with $36 billion of assets under management in high growth markets across the United States, the UK and Ireland. Drawing on decades of experience, its relationship-oriented team excels at identifying opportunities and building value through market cycles, closing more than $60 billion in total transactions across the property spectrum since going public in 2009. Kennedy Wilson owns, operates, and builds real estate within its high-quality, core real estate portfolio and through its investment management platform, where the company targets opportunistic equity and debt investments alongside partners. For further information, please visit www.kennedywilson.com.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended, which are made pursuant to the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995 and any applicable Canadian securities regulations. These forward-looking statements are necessarily estimates reflecting the judgment of the Company’s senior management based on the Company’s current estimates, expectations, forecasts and projections and include comments that express the Company’s current opinions about trends and factors that may impact future results. Disclosures that use words such as “believe,” “may,” “anticipate,” “estimate,” “intend,” “could,” “plan,” “expect,” “project” or the negative of these, as well as similar expressions, are intended to identify forward-looking statements.

Forward-looking statements involve significant known and unknown risks and uncertainties that may cause the Company’s actual results in future periods to differ materially from those projected or contemplated in the forward-looking statements. The inclusion of such statements should not be regarded as a representation that such plans, estimates or expectations will be achieved.

Forward-looking statements are not guarantees of future performance, rely on a number of assumptions concerning future events, many of which are outside of the Company’s or Fairfax’s control, and involve known and unknown risks and uncertainties that could cause the Company’s or Fairfax’s actual results, performance or achievement, or industry results to differ materially from any future results, performance or achievements, expressed or implied by such forward-looking statements. These risks and uncertainties may include the risks and uncertainties described elsewhere in this press release and other filings with the SEC and with the securities regulatory authorities in Canada. Any such forward-looking statements, whether made in this press release or elsewhere, should be considered in the context of the various disclosures made by the Company or Fairfax, as applicable, about its businesses including, without limitation, the risk factors discussed in the Company’s and Fairfax’s filings with the SEC and the securities regulatory authorities in Canada.

Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date thereof. Except as required by applicable law, neither the Company nor Fairfax undertakes any obligation to update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

KW-IR

More News From Kennedy-Wilson, Inc.

10.48K Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

PEMBROKE, Bermuda--(BUSINESS WIRE)--Arch Capital Group Ltd. (NASDAQ: ACGL) (“Arch” or the “Company”) today announced the total consideration payable for the previously announced cash tender offers (the “Tender Offers”) by its wholly-owned subsidiaries, (x) Arch Capital Group (U.S.) Inc. (the “2043 Notes Offeror”) of its outstanding 5.144% Senior Notes due 2043 (the “2043 Notes”) and (y) Arch Capital Finance LLC (the “2046 Notes Offeror” and, together with the 2043 Notes Offeror, the “Offerors”) of its outstanding 5.031% Senior Notes due 2046 (the “2046 Notes” and together with the 2043 Notes, collectively, the “Notes” and each a “Series” of Notes), for an aggregate principal amount of up to $417,851,000 (the “Maximum Amount”) in the order of priority shown in the table below. Capitalized terms used in this press release and not defined herein have the meanings given to them in the Offer to Purchase, dated June 2, 2026 (the “Offer to Purchase”).

The table below sets forth, among other things, the aggregate principal amount of the Notes validly tendered and not validly withdrawn as of 5:00 p.m., New York City time, on June 15, 2026 (such date and time, the “Early Tender Deadline”) and expected to be accepted for purchase in each Tender Offer, the approximate proration factor for the Notes and the Total Consideration for the Notes, as calculated by the Dealer Managers at 10:00 a.m., New York City time, June 16, 2026 (such date and time, as the same may be extended, the “Price Determination Date”).

Title of Security

CUSIP / ISIN(1)

Original Issuer

Aggregate Principal Amount Outstanding

Acceptance Priority Level(2)

Reference U.S. Treasury Security

Bloomberg Reference Page(3)

Early Tender Premium(4)

Fixed Spread (bps)(5)

Reference Yield

Principal Amount Tendered at Early Tender Deadline

Principal Amount Expected to be Accepted

Approximate Proration Factor

Total Consideration(5)(6)

5.144% Senior Notes due 2043

03938JAA7 / US03938JAA79

Arch Capital Group (U.S.) Inc.

$500,000,000

1

5.00% U.S. Treasury due May 15 2046

FIT1

$50

+55 bps

4.954%

$218,712,000

$218,712,000

N/A

$960.00

5.031% Senior Notes due 2046

03939CAB9 / US03939CAB90

Arch Capital Finance LLC

$450,000,000

2

5.00% U.S. Treasury due May 15 2046

FIT1

$50

+55 bps

4.954%

$199,139,000

$199,139,000

N/A

$942.30

________________

(1)

No representation is made as to the correctness or accuracy of the CUSIP/ISIN numbers listed in this press release, the Offer to Purchase or printed on the Notes. They are provided solely for convenience.

(2)

The Maximum Amount of Notes that may be purchased in the Tender Offers is the aggregate amount of Notes that will not result in the Aggregate Purchase Price for Notes validly tendered and accepted for purchase pursuant to the Tender Offers exceeding the Maximum Amount. The Offerors reserve the right, in their sole discretion, subject to applicable law, to further increase or decrease the Maximum Amount, but there can be no assurance that the Offerors will do so. Notes accepted for purchase on any Settlement Date will be accepted in accordance with their Acceptance Priority Levels set forth herein (with “1” being the highest Acceptance Priority Level and “2” being the lowest Acceptance Priority Level). The Offerors will only accept for purchase Notes up to an aggregate principal amount that will not result in the Aggregate Purchase Price to exceed the Maximum Amount.

(3)

The Bloomberg Reference Page is provided for convenience only.

(4)

Per $1,000 principal amount of Notes validly tendered prior to or at the Early Tender Deadline and expected to be accepted for purchase.

(5)

Includes the Early Tender Premium of $50 per $1,000 principal amount of Notes for each Series (the “Early Tender Premium”) as set forth in the Offer to Purchase, which will be paid in addition to the Total Tender Offer Consideration or Late Tender Offer Consideration, as applicable.

(6)

The Total Consideration for the Notes validly tendered prior to or at the Early Tender Deadline and expected to be accepted for purchase is calculated using the Fixed Spread and is inclusive of the Early Tender Premium. The Total Consideration for the Notes does not include the accrued and unpaid interest, which will be payable in addition to the Total Consideration.

The Tender Offers are subject to the satisfaction of certain conditions as set forth in the Offer to Purchase; as of the date hereof, the Financing Condition described in the Offer to Purchase has been satisfied. Subject to applicable law, the Offerors may waive any and all of these conditions or extend, terminate or withdraw the Tender Offers with respect to one or more Series of Notes or further increase or decrease the Maximum Amount, including on or after the Price Determination Date. The Tender Offers are not conditioned upon any minimum amount of Notes being tendered.

Withdrawal rights for the Notes expired on the Early Tender Deadline. The Company expects to make payment on June 18, 2026 (the “Early Settlement Date”) for Notes that were validly tendered prior to or at the Early Tender Deadline and that are accepted for purchase. The Tender Offers are scheduled to expire at 5:00 p.m., New York City time, on July 1, 2026, unless extended or earlier terminated as described in the Offer to Purchase (such time and date, as it may be extended, the “Expiration Date”). Because the Notes validly tendered and not validly withdrawn prior to or at the Early Tender Deadline have an aggregate principal amount that is equal to the Maximum Amount, the Company does not expect to accept for purchase any Notes tendered after the Early Tender Deadline.

The Total Consideration listed in the table above will be paid per $1,000 principal amount of the Notes validly tendered and accepted for purchase pursuant to the Tender Offers on the Early Settlement Date. Only holders of Notes who validly tendered and did not validly withdraw their Notes prior to or at the Early Tender Deadline are eligible to receive the Total Consideration for Notes accepted for purchase. Holders will also receive accrued and unpaid interest on Notes validly tendered and accepted for purchase from the last interest payment date up to, but not including, the Early Settlement Date.

From time to time, the Offerors, the Company or any of their respective affiliates may purchase additional Notes in the open market, in privately negotiated transactions, through tender offers or otherwise, or may redeem Notes pursuant to the terms of the applicable indenture governing a Series of Notes. Any future purchases or redemptions may be on the same terms or on terms that are more or less favorable to Holders of Notes than the terms of the Tender Offers. Any future purchases by the Offerors, the Company or any of their respective affiliates will depend on various factors existing at that time. There can be no assurance as to which, if any, of these alternatives (or combinations thereof) the Offerors, the Company or any of their respective affiliates may choose to pursue in the future. The effect of any of these actions may directly or indirectly affect the price of any Notes that remain outstanding after the consummation or termination of the Tender Offer.

Notwithstanding any other provision of the Tender Offers, the Offerors will not be obligated to accept for purchase, and pay for, validly tendered Notes of any Series pursuant to the Tender Offers if the conditions set forth in the Offer to Purchase have not been satisfied, or waived by the Offeror, with respect to such Series of Notes.

Wells Fargo Securities, LLC and BofA Securities, Inc. are serving as Dealer Managers for the Tender Offers. Global Bondholder Services Corporation is the Tender and Information Agent. Persons with questions regarding the Tender Offers should contact Wells Fargo Securities, LLC at (866) 309-6316 (toll-free) or at (704) 410-4820 (collect) or BofA Securities, Inc. at (888) 292-0070 (toll-free) or at (980) 388-0539 (collect). Questions regarding the tendering of Notes and requests for copies of the Offer to Purchase and related materials should be directed to Global Bondholder Services Corporation at 212-430-3774 (banks and brokers) or 855-654-2015 (toll-free), in writing at 65 Broadway – Suite 404, New York, New York 10066 or by email at [email protected].

This press release is neither an offer to purchase nor a solicitation of an offer to sell the Notes. The Tender Offers are made only by the Offer to Purchase and the information in this press release is qualified by reference to the Offer to Purchase. There is no separate letter of transmittal in connection with the Offer to Purchase. None of the Offerors, Company, their respective board of directors or managers, the Dealer Managers, the Tender and Information Agent or the trustees with respect to any Notes is making any recommendation as to whether holders should tender any Notes in response to the Tender Offers, and none of the Offerors, the Company nor any such other person has authorized any person to make any such recommendation. Holders must make their own decision as to whether to tender any of their Notes, and, if so, the principal amount of Notes to tender.

About Arch Capital Group Ltd.

Arch Capital Group Ltd. (Nasdaq: ACGL) is a publicly listed Bermuda exempted company with approximately $26.9 billion in capital at March 31, 2026. Arch, which is part of the S&P 500 Index, provides insurance, reinsurance and mortgage insurance on a worldwide basis through its wholly owned subsidiaries.

Cautionary Note Regarding Forward-Looking Statements

The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. This release or any other written or oral statements made by or on behalf of Arch Capital Group Ltd. and its subsidiaries may include forward-looking statements, which reflect the Company’s current views with respect to future events and financial performance. All statements other than statements of historical fact included in or incorporated by reference in this release are forward-looking statements.

Forward-looking statements can generally be identified by the use of forward-looking terminology such as "may," "will," "expect," "intend," "estimate," "anticipate," "believe" or "continue" or their negative or variations or similar terminology. Forward-looking statements involve the Company’s current assessment of risks and uncertainties. Actual events and results may differ materially from those expressed or implied in these statements. A non-exclusive list of the important factors that could cause actual results to differ materially from those in such forward-looking statements includes the following: adverse general economic and market conditions; increased competition; pricing and policy term trends; fluctuations in the actions of rating agencies and the Company’s ability to maintain and improve its ratings; investment performance; the loss of key personnel; the adequacy of the Company’s loss reserves, severity and/or frequency of losses, greater than expected loss ratios and adverse development on claim and/or claim expense liabilities; greater frequency or severity of unpredictable natural and man-made catastrophic events, including the effect of contagious diseases on our business; the impact of acts of terrorism and acts of war; changes in regulations and/or tax laws in the United States or elsewhere; statutory or regulatory developments, including as to tax matters and insurance and other regulatory matters; ability to successfully integrate, establish and maintain operating procedures as well as integrate the businesses the Company has acquired or may acquire into the existing operations; changes in accounting principles or policies; material differences between actual and expected assessments for guaranty funds and mandatory pooling arrangements; availability and cost to the Company of reinsurance to manage our gross and net exposures; the failure of others to meet their obligations to the Company; an incident, disruption in operations or other cyber event caused by cyber attacks, the use of artificial intelligence technologies or other technology on the Company’s systems or those of the Company’s business partners and service providers, which could negatively impact the Company’s business and/or expose the Company to litigation; and the other matters set forth under ITEM 1A “Risk Factors”, Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and other sections of our 2025 10-K, as well as the other factors set forth in our other documents on file with the SEC, and management’s response to any of the aforementioned factors.

The foregoing review of important factors should not be construed as exhaustive and should be read in conjunction with other cautionary statements that are included herein or elsewhere. All subsequent written and oral forward-looking statements attributable to us or persons acting on the Company’s behalf are expressly qualified in their entirety by these cautionary statements. The Company’s forward-looking statements speak only as of the date of this press release or as of the date they are made, and the Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

Source: Arch Capital Group Ltd.
arch-corporate

More News From Arch Capital Group Ltd.

PEMBROKE, Bermuda--(BUSINESS WIRE)--Arch Capital Group Ltd. (NASDAQ: ACGL) (“Arch” or the “Company”), a leading provider of insurance, reinsurance and mortgage insurance globally, today announced the promotions of Jerome Halgan to CEO of Arch Global Reinsurance Group and Michael Schmeiser to CEO of Arch Global Mortgage Group. Both will continue to report to Arch President Maamoun Rajeh. “Jerome and Michael are experienced leaders who are deeply grounded in Arch's underwriting culture and corpor.

Key Takeaways ACGL has delivered steady premium expansion, with net premiums written seeing a 17.4% CAGR from 2018 to 2025. Rate increases, new business and growth within existing accounts continue to support organic momentum. Strong positions in insurance and reinsurance, backed by a robust capital base, support long-term growth. Shares of Arch Capital Group Ltd. (ACGL - Free Report) have gained 2.7% in the past year, outperforming its industry’s appreciation of 0.9%.

Arch Capital has outperformed its peers, including The Progressive Corporation (PGR - Free Report) , NMI Holdings Inc. (NMIH - Free Report) and W.R. Berkley Corporation (WRB - Free Report) . Shares of PGR, NMIH and WRB have lost 23%, 4.1% and 6.2%, respectively, in the last six-month period.

Image Source: Zacks Investment Research

ACGL’s Expensive ValuationBased on the forward 12-month price-to-book ratio, Arch Capital is currently trading at 1.41X, above its industry average of 1.4X. The insurer has a Value Score of A.

ACGL Growth ProjectionThe Zacks Consensus Estimate for Arch Capital’s 2027 earnings per share and revenues indicates a year-over-year increase of 7.5% and 2.2%, respectively, from the corresponding 2026 estimates. Earnings have grown 30% in the past five years, better than the industry average of 22.7%.

Earnings Surprise HistoryThe insurer has a solid track record of beating earnings estimates in each of the past four quarters, with an average of 14.97%.

Return on Capital of ACGLArch Capital’s trailing 12-month return on equity is 17.6%, ahead of the industry average of 7.4%. Return on equity, a profitability measure, reflects how effectively a company is utilizing its shareholders’ equity.

Average Target Price for ACGL Suggests UpsideBased on short-term price targets offered by 20 analysts, the Zacks average price target is $108.33 per share. The average suggests a potential 18.39% upside from the last closing price.

Image Source: Zacks Investment Research

Key Points to Note for ACGL StockArch Capital’s well-rounded product portfolio and consistent premium growth highlight the strength of its organic drivers. Rate increases, new business inflows and expansion within existing accounts continue to fuel its momentum. Additionally, its ability to scale organically across specialty insurance and reinsurance underscores sustained growth potential.

Building on this momentum, Arch Capital has delivered steady premium acceleration, with net premiums written registering a seven-year (2018-2025) CAGR of 17.4%. The combination of firm market rates, inflation-led demand and disciplined underwriting has strengthened growth across P&C lines.

Arch Capital is also benefiting from favorable dynamics in the P&C market, where a hardening environment is supporting higher premiums and stronger demand for coverage. While industry-wide pressures, such as catastrophe losses and inflation, have intensified claims costs, they have also driven rate momentum. With its underwriting discipline, global distribution and focus on specialty lines, Arch Capital is well-placed to capitalize on these conditions.

End NotesOverall, Arch Capital continues to benefit from strong organic growth drivers, steady premium momentum and a solid competitive position in key markets.

Arch Capital boasts a strong product portfolio and has a solid track record of premium growth, as well as favorable return on capital. Both the Insurance and Reinsurance segments should continue to witness significant growth from increases in most lines of business. A robust capital position over the years reflects its financial flexibility.

Its solid growth projections, higher target price and favorable return on capital should continue to benefit Arch Capital over the long term. The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

In the latest close session, Sterling Infrastructure (STRL - Free Report) was down 1.03% at $857.76. This change lagged the S&P 500's daily loss of 0.57%. Elsewhere, the Dow gained 0.64%, while the tech-heavy Nasdaq lost 1.15%.

Heading into today, shares of the civil construction company had gained 12.44% over the past month, outpacing the Construction sector's gain of 4.86% and the S&P 500's gain of 2.14%.

The investment community will be closely monitoring the performance of Sterling Infrastructure in its forthcoming earnings report. On that day, Sterling Infrastructure is projected to report earnings of $5.39 per share, which would represent year-over-year growth of 100.37%. Meanwhile, our latest consensus estimate is calling for revenue of $1.07 billion, up 74.03% from the prior-year quarter.

Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $19.31 per share and revenue of $3.96 billion, indicating changes of +77.48% and +59.15%, respectively, compared to the previous year.

Investors should also note any recent changes to analyst estimates for Sterling Infrastructure. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.

Our research shows that these estimate changes are directly correlated with near-term stock prices. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.

The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 2.89% increase. As of now, Sterling Infrastructure holds a Zacks Rank of #1 (Strong Buy).

With respect to valuation, Sterling Infrastructure is currently being traded at a Forward P/E ratio of 44.88. This represents a premium compared to its industry average Forward P/E of 38.19.

It's also important to note that STRL currently trades at a PEG ratio of 2.99. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. STRL's industry had an average PEG ratio of 2.08 as of yesterday's close.

The Engineering - R and D Services industry is part of the Construction sector. This industry, currently bearing a Zacks Industry Rank of 83, finds itself in the top 35% echelons of all 250+ industries.

The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.

Most of us have heard the dictum "the trend is your friend." And this is undeniably the key to success when it comes to short-term investing or trading. But it isn't easy to ensure the sustainability of a trend and profit from it.

The trend often reverses before exiting the trade, leading to a short-term capital loss for investors. So, for a profitable trade, one should confirm factors such as sound fundamentals, positive earnings estimate revisions, etc. that could keep the momentum in the stock alive.

Investors looking to make a profit from stocks that are currently on the move may find our "Recent Price Strength" screen pretty useful. This predefined screen comes handy in spotting stocks that are on an uptrend backed by strength in their fundamentals, and trading in the upper portion of their 52-week high-low range, which is usually an indicator of bullishness.

Sterling Infrastructure (STRL - Free Report) is one of the several suitable candidates that passed through the screen. Here are the key reasons why it could be a profitable bet for "trend" investors.

A solid price increase over a period of 12 weeks reflects investors' continued willingness to pay more for the potential upside in a stock. STRL is quite a good fit in this regard, gaining 107.2% over this period.

However, it's not enough to look at the price change for around three months, as it doesn't reflect any trend reversal that might have happened in a shorter time frame. It's important for a potential winner to maintain the price trend. A price increase of 17.5% over the past four weeks ensures that the trend is still in place for the stock of this civil construction company.

Moreover, STRL is currently trading at 81.8% of its 52-week High-Low Range, hinting that it can be on the verge of a breakout.

Looking at the fundamentals, the stock currently carries a Zacks Rank #1 (Strong Buy), which means it is in the top 5% of more than the 4,000 stocks that we rank based on trends in earnings estimate revisions and EPS surprises -- the key factors that impact a stock's near-term price movements.

The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

Another factor that confirms the company's fundamental strength is its Average Broker Recommendation of #1 (Strong Buy). This indicates that the brokerage community is highly optimistic about the stock's near-term price performance.

So, the price trend in STRL may not reverse anytime soon.

In addition to STRL, there are several other stocks that currently pass through our "Recent Price Strength" screen. You may consider investing in them and start looking for the newest stocks that fit these criteria.

This is not the only screen that could help you find your next winning stock pick. Based on your personal investing style, you may choose from over 45 Zacks Premium Screens that are strategically created to beat the market.

However, keep in mind that the key to a successful stock-picking strategy is to ensure that it produced profitable results in the past. You could easily do that with the help of the Zacks Research Wizard. In addition to allowing you to backtest the effectiveness of your strategy, the program comes loaded with some of our most successful stock-picking strategies.

Click here to sign up for a free trial to the Research Wizard today.

-

Zero-configuration, autonomously initiated investigations run inside customers’ existing Singularity™ Platform workflows, detecting, investigating, and responding to threats at machine speed, and giving every analyst a force multiplier, with a full evidence chain behind every verdict

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--SentinelOne® (NYSE: S), the AI security leader, today opened Purple AI Agentic Investigation to its customers and introduced Singularity Credits, a unified currency for running AI-powered work across the Singularity Platform. Starting this week, customers can opt into a complimentary trial of the newest capability from Purple AI, SentinelOne’s autonomous security reasoning for the agentic SOC. That capability — ‘zero-click,’ autonomously initiated investigations — detects, investigates, verifies, and responds to threats without human dependencies. When a threat crosses a defined threshold, Purple AI investigates, renders a verdict, and stops it at machine speed, while analysts keep full visibility and control.

The capability arrives as security teams confront a hard limit, not detection, but investigation capacity. Detections climb with every new tool and every expansion of the attack surface, alerts queue for attention, and verdicts wait on analyst availability, with coverage thinning on nights, weekends, and during surges. Frontier-AI-powered threats are poised to widen that gap further.

“Today’s security teams face more critical alerts than any staffing plan could investigate, and AI-powered threats are only going to make that worse,” said Chris Corde, Chief Product Officer of SentinelOne. “Investigation capacity has become the binding constraint of the modern SOC: detections climb, alerts queue, and verdicts wait on analyst availability. Purple AI’s Agentic Investigation capability is designed to remove that constraint by making investigations automatic, continuous, and immediate.”

Why SOC Teams Are Adopting Purple AI Agentic Investigation

Seamlessly integrated — zero configuration, working from day one
Purple AI is built into the Singularity Platform, not bolted onto it. The new Agentic Investigation capability runs on telemetry already in the platform across endpoint, identity, cloud, and third-party security data, as well as inside the automated workflows customers already use. There is nothing to deploy, integrate, or tune, and no data leaves the platform. Activation is a single click. A force multiplier for every analyst
Purple AI does the investigation work, collecting evidence, correlating telemetry, and building the attack timeline, so analysts start at the verdict instead of the alert. It scales a team’s investigation capacity without scaling headcount, and frees analysts for the judgment, threat hunting, and response decisions that need a human. It is designed as an extension of the analyst: amplifying human defenders, not replacing them. Fully audited — governed autonomy, no black box
Every verdict carries a complete, auditable evidence chain, so analysts can review each AI step and outcome with confidence. Customers set the degree of autonomy through an adjustable human-in-the-loop approach that scales to their confidence and SOC maturity. Verdicts can trigger automated, policy-driven responses, or prompt an analyst with recommended actions. Activation is admin-controlled, role-based, and reversible at any time, and consumption guardrails keep usage and downstream cost in the hands of those with the right authority. Built on the most advanced reasoning in cybersecurity
Purple AI is the reasoning brain and interface for the entire Singularity Platform. It brings human-level reasoning from advanced frontier-AI models to bear through a multi-model approach, combining Anthropic’s Claude, OpenAI’s GPT, and SentinelOne’s proprietary “Ultraviolet” models to compress investigations that once took hours or days into minutes and seconds. For critical threats, investigations trigger automatically and deliver verdicts that can be acted on autonomously or by an analyst. The introduction of Singularity Credits

Singularity Credits are a flexible, unified currency customers draw down across AI-powered work in the Singularity Platform, including Purple AI Agentic Investigation. To start, SentinelOne is granting customers a complimentary allotment of Credits to trial the capability.

Delivering on the agentic SOC by amplifying defenders, not replacing them

Agentic Investigation advances SentinelOne’s vision of the agentic SOC: one where frontier-AI reasoning amplifies and scales human defenders rather than sidelining them. Purple AI acts as the brain and interface for the entire platform from simplifying querying, to recommending actions, to autonomously detecting, triaging, and stopping threats. Because it operates natively on AI, endpoint, identity, cloud, and third-party telemetry already in the Singularity Platform, it drives Singularity to be an agentic realization of the integrated security operations center (ISOC) category defined by Gartner.

Availability & access

The Purple AI Agentic Investigation trial is now available in Singularity Platform consoles. New and existing Singularity customers can opt in and begin running agentic investigations immediately. Investigations utilize Singularity Credits during the trial, but customers are not charged and no payment method is required. After the trial, customers can purchase Singularity Credits through partners, direct billing, and eCommerce.

About SentinelOne

SentinelOne (NYSE: S) is the leader in AI security, setting the standard for using AI and automation to give defenders a decisive operating advantage. Built for those who secure our world, its platform delivers unified coverage across endpoints, identity, cloud, and AI. Powered by Autonomous Security Intelligence, SentinelOne stops attacks at machine speed, reducing risk and delivering clarity and control to stay one step ahead. Headquartered in Mountain View, California, with teams worldwide, SentinelOne protects nearly one-fifth of the Fortune 500 and hundreds of Global 2000 enterprises. From Main Street to Wall Street, the world’s most critical organizations trust SentinelOne with their security.

All third-party product names, logos, and brands mentioned in this publication are the property of their respective owners and are for identification purposes only. Use of these names, logos, and brands does not imply affiliation, endorsement, sponsorship, or association with the third party.

More News From SentinelOne

Back to Newsroom

SentinelOne® (NYSE: S), the AI Security leader, today announced its upcoming integration with Amazon Bedrock AgentCore. The integration will be delivered through SentinelOne’s Prompt Security offering. The integration reflects SentinelOne’s commitment to extending the security controls customers already trust into agentic workflows, empowering enterprises deploying AI on AWS to secure and scale their AI workflows.

Amazon Bedrock AgentCore is the platform to build, connect, and optimize agents at scale. Through its policy engine, AgentCore enforces real-time, deterministic controls at the gateway across all agent traffic including agent-to-tool, agent-to-LLM, and agent-to-agent communications. With this integration, SentinelOne’s Prompt Security will provide detection signals covering prompt injection detection, PII exposure, tool-use validation, LLM response monitoring, and data leakage prevention that feed into AgentCore policy engine. AgentCore acts on those signals at the gateway, outside the agent’s reasoning loop, so enterprise teams can apply SentinelOne’s detection signals alongside deterministic, automated enforcement consistently across all agent activity. Because detection can be probabilistic, but enforcement stays deterministic, customers gain consistent allow-or-deny decisions on every agent action, allowing organizations to adopt agentic AI at enterprise scale with the confidence that existing SentinelOne security controls apply automatically throughout every agentic workflow.

“Agentic AI has become foundational to how enterprises operate,” said Melissa K. Smith, SVP of Global Strategic Partnerships and Initiatives at SentinelOne. “Every organization building and running AI agents on AWS needs the same security controls they rely on across the rest of their infrastructure. This upcoming integration applies those guardrails at the AgentCore gateway, where all agent traffic is evaluated, giving every enterprise the confidence to deploy AI agents knowing their existing SentinelOne policies apply automatically, from day one.”

The upcoming integration will be available in Amazon Bedrock AgentCore later this year. Customers with existing Prompt Security licenses will apply them through a Bring Your Own License path. As enterprise AI agent deployments scale, consumption scales with them.

Customers can learn more about SentinelOne’s integration with Amazon Bedrock AgentCore at sentinelone.com.

About SentinelOne

SentinelOne (NYSE: S) is the leader in AI security, setting the standard for using AI and automation to give defenders a decisive operating advantage. Built for those who secure our world, its platform delivers unified coverage across endpoints, identity, cloud, and AI. Powered by Autonomous Security Intelligence, SentinelOne stops attacks at machine speed, reducing risk and delivering clarity and control to stay one step ahead. Headquartered in Mountain View, California with teams worldwide, SentinelOne protects nearly one-fifth of the Fortune 500 and hundreds of Global 2000 enterprises. From Main Street to Wall Street, the world’s most critical organizations trust SentinelOne with their security.

Forward-Looking Statements

This press release includes forward-looking statements. Forward-looking statements are subject to risks and uncertainties, including factors beyond our control, that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. These and other risk factors are described in the “Risk Factors” section of our most recent Annual Report on Form 10-K, subsequently quarterly reports filed on Form 10-Q, and other filings made with the U.S. Securities and Exchange Commission (SEC), which are available free of charge on our website at investors.sentinelone.com and on the SEC’s website at www.sec.gov. You are cautioned not to place undue reliance on these forward-looking statements. Any future products, functionality and services may be abandoned or delayed, and as such, you should make decisions to purchase products and services based on features that are currently available. Any forward-looking statements made herein are based on our beliefs and assumptions that we believe to be reasonable as of the date hereof. You should not rely upon forward-looking statements as predictions of future events. Except to the extent required by law, we undertake no obligation to update these forward-looking statements to reflect new information or future events.

Third-Party Disclaimer

All third-party product names, logos, and brands mentioned in this publication are the property of their respective owners and are for identification purposes only. Use of these names, logos, and brands does not imply affiliation, endorsement, sponsorship, or association with the third party.

Category: Investors

View source version on businesswire.com: https://www.businesswire.com/news/home/20260617521014/en/

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though?

Let's take a look at what these Wall Street heavyweights have to say about SentinelOne (S - Free Report) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.

SentinelOne currently has an average brokerage recommendation (ABR) of 1.75, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 36 brokerage firms. An ABR of 1.75 approximates between Strong Buy and Buy.

Of the 36 recommendations that derive the current ABR, 22 are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 61.1% and 2.8% of all recommendations.

Brokerage Recommendation Trends for S

Check price target & stock forecast for SentinelOne here>>>

The ABR suggests buying SentinelOne, but making an investment decision solely on the basis of this information might not be a good idea. According to several studies, brokerage recommendations have little to no success guiding investors to choose stocks with the most potential for price appreciation.

Are you wondering why? The vested interest of brokerage firms in a stock they cover often results in a strong positive bias of their analysts in rating it. Our research shows that for every "Strong Sell" recommendation, brokerage firms assign five "Strong Buy" recommendations.

In other words, their interests aren't always aligned with retail investors, rarely indicating where the price of a stock could actually be heading. Therefore, the best use of this information could be validating your own research or an indicator that has proven to be highly successful in predicting a stock's price movement.

With an impressive externally audited track record, our proprietary stock rating tool, the Zacks Rank, which classifies stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), is a reliable indicator of a stock's near-term price performance. So, validating the Zacks Rank with ABR could go a long way in making a profitable investment decision.

ABR Should Not Be Confused With Zacks RankIn spite of the fact that Zacks Rank and ABR both appear on a scale from 1 to 5, they are two completely different measures.

Broker recommendations are the sole basis for calculating the ABR, which is typically displayed in decimals (such as 1.28). The Zacks Rank, on the other hand, is a quantitative model designed to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.

It has been and continues to be the case that analysts employed by brokerage firms are overly optimistic with their recommendations. Because of their employers' vested interests, these analysts issue more favorable ratings than their research would support, misguiding investors far more often than helping them.

On the other hand, earnings estimate revisions are at the core of the Zacks Rank. And empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

Furthermore, the different grades of the Zacks Rank are applied proportionately across all stocks for which brokerage analysts provide earnings estimates for the current year. In other words, at all times, this tool maintains a balance among the five ranks it assigns.

There is also a key difference between the ABR and Zacks Rank when it comes to freshness. When you look at the ABR, it may not be up-to-date. Nonetheless, since brokerage analysts constantly revise their earnings estimates to reflect changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in predicting future stock prices.

Should You Invest in S?Looking at the earnings estimate revisions for SentinelOne, the Zacks Consensus Estimate for the current year has increased 19.8% over the past month to $0.35.

Analysts' growing optimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates higher, could be a legitimate reason for the stock to soar in the near term.

The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #2 (Buy) for SentinelOne. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

Therefore, the Buy-equivalent ABR for SentinelOne may serve as a useful guide for investors.

Simply Good Foods (SMPL +4.04%) is one of those companies you run into more often than you think. The bars are common in any health center or aerobics hall, and strong sellers in e-commerce channels.

At the same time, something's missing. As of June 16, the stock is down 62% over the past year. Its earnings reports have been a mixed bag, and the misses against Wall Street's revenue estimates have been painful in recent years.

Simply Good Foods is trading in Wall Street's bargain bin. Is the company set up for a lucrative turnaround?

Today's Change

(

4.04

%) $

0.49

Current Price

$

12.63

The Atkins brand needs a protein boost Let's start with last month's Q2 2026 report. Simply Good Foods fell short on the top line by a wide margin. Moreover, management provided next-quarter revenue guidance far below the Street consensus at the time.

The company stepped down an ambitious marketing and discount program for the Atkins brand, setting it up for difficult comparisons. The lower ad budget was based on weaker consumer interest in the Atkins message, which promotes a low-carb and high-protein lifestyle like the namesake diet. Simply Good Foods will continue to "right-size" its Atkins advertising for the rest of 2026.

GLP-1 drugs like Ozempic aren't helping the weight-loss focus of Atkins, either.

"Our research clearly shows an opportunity to position Atkins as an ally to consumers using or coming off of these drugs," CEO Geoff Tanner said on the Q2 earnings call. The company is viewing Atkins products as a complement to other weight-loss products, not a comprehensive solution. This plan sounds difficult.

Image source: Getty Images.

A bargain-bin price with some strings attached At 7.1 times forward earnings and 7.8 times free cash flow, Simply Good Foods is priced like a clearance-rack item. But Atkins doesn't have to perk up right away.

The 2024 acquisition of OWYN ("only what you need") is already paying off. OWYN sales rose 52% year over year. If management can stabilize Atkins while the OWYN and Quest segments keep growing, the turnaround math solves itself.

Here's the catch: recent quarters haven't inspired much confidence in a smooth turnaround. Short interest has climbed to 8.2% of float, up from 4.8% a year ago. That's unusual and troubling for a stock in freefall.

Simply Good Foods may deserve a place in a diversified portfolio, but as a smaller, speculative position.

MKS (MKSI - Free Report) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with analysts still raising their earnings estimates for the company.

The rising trend in estimate revisions, which is a result of growing analyst optimism on the earnings prospects of this maker of analysis and processing equipment for semiconductor companies, should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. Our stock rating tool -- the Zacks Rank -- is principally built on this insight.

The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Strong Buy) to a Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record of outperformance, with Zacks #1 Ranked stocks generating an average annual return of +25% since 2008.

For MKS, there has been strong agreement among the covering analysts in raising earnings estimates, which has helped push consensus estimates considerably higher for the next quarter and full year.

The chart below shows the evolution of forward 12-month Zacks Consensus EPS estimate:

12 Month EPS

Current-Quarter Estimate RevisionsFor the current quarter, the company is expected to earn $2.92 per share, which is a change of +65.0% from the year-ago reported number.

Over the last 30 days, one estimate has moved higher for MKS compared to no negative revisions. As a result, the Zacks Consensus Estimate has increased 5.83%.

Current-Year Estimate RevisionsFor the full year, the company is expected to earn $11.73 per share, representing a year-over-year change of +48.9%.

In terms of estimate revisions, the trend for the current year also appears quite encouraging for MKS. Over the past month, three estimates have moved higher compared to no negative revisions, helping the consensus estimate increase 5.34%.

Favorable Zacks RankThanks to promising estimate revisions, MKS currently carries a Zacks Rank #1 (Strong Buy). The Zacks Rank is a tried-and-tested rating tool that helps investors effectively harness the power of earnings estimate revisions and make the right investment decision.

You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

Our research shows that stocks with Zacks Rank #1 (Strong Buy) and 2 (Buy) significantly outperform the S&P 500.

Bottom LineInvestors have been betting on MKS because of its solid estimate revisions, as evident from the stock's 24.6% gain over the past four weeks. As its earnings growth prospects might push the stock higher, you may consider adding it to your portfolio right away.

-

LOS ANGELES--(BUSINESS WIRE)--Korn Ferry (NYSE:KFY) today announced that the firm will release financial results for the fourth quarter of full fiscal year 2026 (ended April 30, 2026) on Tuesday, June 23, 2026.

A press release will be issued before the market opens on Tuesday, June 23, 2026, followed by a live webcast at 12:00 pm EST.

What:

  Korn Ferry to Report Q4 FY2026 Earnings
Investor Live Webcast

  When:

  12:00 pm EST on Tuesday, June 23, 2026.

  Where:

  Live audio webcast and accompanying slides will be available at the following site:
https://ir.kornferry.com/events-and-presentations

About Korn Ferry

Korn Ferry is a global consulting firm that powers performance. We unlock the potential in your people and unleash transformation across your business—synchronizing strategy, operations, and talent to accelerate performance, fuel growth, and inspire a legacy of change. That’s why the world’s most forward-thinking companies across every major industry turn to us—for a shared commitment to lasting impact and the bold ambition to Be More Than.

As the Official Talent & Organizational Consulting Partner of LA28, Korn Ferry is powering the nearly 5,000 people who power the Olympic Games—bringing in the right talent, building strong leaders, and shaping the structure and culture that will deliver an unforgettable experience for the world.

More News From Korn Ferry

Back to Newsroom

MILAN, June 18, 2026 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the launch of the firm’s energy advisory offering in Italy with the appointment of Riccardo Siliprandi as a Senior Managing Director in the Economic Consulting segment. His arrival signals the expansion of FTI Consulting’s offering in Italy, building on the firm’s existing capabilities in transactions and transformation.

In his role at the firm, Dr. Siliprandi will lead FTI Consulting’s Energy practice in Italy, providing clients with contentious and non-contentious support across the infrastructure lifecycle, from transactions due diligence, merger and acquisitions (“M&A”) and portfolio assessments through to damage valuations, arbitrations and expert witness advisory services. He is based in Milan.

“We are delighted to welcome Riccardo to FTI Consulting at an important time for both our firm and the energy sector,” said Emanuele Grasso, Italy Leader and Head of Italy Corporate Finance at FTI Consulting. “Riccardo combines deep sector expertise with commercial, hands-on experience helping companies with critical transformations and fast-moving conditions in the sector. His arrival is an exciting milestone for our business in Italy, as it marks the start of the expansion of our advisory capabilities beyond corporate finance, enabling us to provide even broader support to clients as their needs evolve.”

“Decarbonisation, modernisation and changing energy security needs will reshape the energy sector over the next decade, influencing investment, policy and strategy worldwide,” said Jason Mann, Leader of the Regulated Industries and Energy Markets group at FTI Consulting. “Riccardo has an impressive track record helping companies adapt to these shifts. His appointment reinforces our global commitment to delivering integrated, cross-border expertise that helps energy companies, investors and institutions navigate this fast-evolving market and opportunities with confidence. Together with colleagues across our global Energy team, I look forward to working with Riccardo.”

Dr. Siliprandi brings more than 15 years of energy consulting, industry and academia experience to FTI Consulting. He has advised leading energy companies, international investment funds, utilities and public institutions across Italy, Europe and other jurisdictions around the world on a range of matters, including transformation and decarbonisation strategies, market analysis, business development, M&A and financing.

In addition to leading modelling, pricing and high-impact regulatory and market design studies internationally, Dr. Siliprandi has a particular expertise in energy transition, market entry, electricity, investment and transformation projects. He has also been an expert witness in numerous dispute cases under international arbitration and Italian law.

Prior to joining FTI Consulting, Dr. Siliprandi was a Senior Principal at AFRY Management Consulting, building on earlier experience in industry and academic research. He holds a PhD from The University of Milano-Bicocca in Milan.

Commenting on his appointment, Dr. Siliprandi said, “The goal of energy companies in Italy and around the world is to stay competitive and be prepared for the future. That requires diverse expertise across transactions, regulation, market strategy and dispute resolution, which are all areas where FTI Consulting excels. I am excited to have the opportunity to help build the firm’s Energy practice in Italy and support clients in achieving results that position them for long-term success.”

About FTI Consulting
FTI Consulting, Inc. is a leading global expert firm for organisations facing crisis and transformation, with more than 8,100 employees located in 32 countries and territories as of March 31, 2026. In certain jurisdictions, FTI Consulting’s services are provided through distinct legal entities that are separately capitalised and independently managed. The Company generated $3.8 billion in revenues during fiscal year 2025. More information can be found at www.fticonsulting.com.

FTI Consulting, Inc.
200 Aldersgate
Aldersgate Street
London, EC1A 4HD

Investor Contact:
Mollie Hawkes
+1.617.747.1791
[email protected]

Media Contact:
Helen Obi
+44 20 7632 5071
[email protected]

-

New Jupiter, FL facility enables RNA therapeutics developers to source critical manufacturing materials from a single, coordinated supplier, simplifying workflows and accelerating development timelines.

JUPITER, Fla.--(BUSINESS WIRE)--TriLink, part of Maravai LifeSciences® (NASDAQ: MRVI), today announced the opening of its GMP enzyme manufacturing facility in Jupiter, Florida, designed to help RNA therapeutic developers simplify sourcing and scale production more efficiently. The facility supports a coordinated supply of key RNA manufacturing and IVT workflow materials from early research through commercial production.

The launch addresses a long-standing pain point for RNA therapeutics developers sourcing critical raw materials — enzymes, nucleotides, cap analogs, and tail technology — from multiple vendors with different quality systems, timelines, and points of contact. Managing different quality systems, timelines, and supply processes can slow development and create manufacturing risk. TriLink is now offering these materials as a coordinated, single-source package designed to simplify development and scale up.

The Jupiter facility was purpose-built for GMP enzyme manufacturing. It features controlled cleanroom environments, validated production processes, and scalable capacity designed to support both clinical-stage programs and commercial supply. Full traceability and quality systems are in place to meet regulatory requirements across major markets.

The facility is already supporting customer programs, with TriLink successfully shipping its first commercial GMP enzyme batch in June 2026. This milestone demonstrates the facility’s operational readiness and ability to provide commercial-scale supply of critical IVT raw materials to RNA therapeutics developers worldwide.

The facility’s flagship product is GMP CleanScribe™ RNA Polymerase that reduces double-stranded RNA (dsRNA) formation by up to 85% compared to standard Wild-type T7 RNA polymerases, a result demonstrated across internal and customer studies. dsRNA is a critical quality attribute in therapeutic mRNA manufacturing: its accumulation drives purification complexity, depresses final RNA purity, and increases immunogenicity risk in vivo. CleanScribe™ RNA Polymerase is engineered specifically for IVT workflows where controlling dsRNA at the synthesis step translates directly into downstream process efficiency and product quality.

An Integrated IVT Raw Materials Solution

TriLink BioTechnologies is now offering a coordinated supply of GMP-grade IVT raw materials:

GMP CleanScribe™ RNA Polymerase Mix GMP NTPs (nucleoside triphosphates) GMP CleanCap® analogs — the industry-standard co-transcriptional capping reagents GMP ModTail™ technology — designed to enhance mRNA stability and in vivo protein expression The integrated offering is designed to reduce vendor complexity, simplify tech transfer, and ensure material consistency across the development lifecycle from IND-enabling studies through BLA submission and commercial launch.

As RNA-based therapeutics move into later-stage clinical development and commercial production, reliable access to manufacturing materials becomes increasingly important. Enzyme performance variability, regulatory gaps in supplier quality systems, and multi-vendor logistics create compounding delays at precisely the stages when speed matters most.

Combining GMP manufacturing, high-performance enzyme design, and coordinated supply with TriLink’s other GMP consumables, is intended to compress this complexity into a single, accountable partner relationship.

“RNA therapeutics developers need reliable supply partners that can support them from early research through commercial manufacturing. By combining enzyme manufacturing capabilities with TriLink’s existing RNA technologies, we help customers simplify sourcing, reduce supply chain complexity, and accelerate scale-up with greater confidence.”

— Chad Decker, SVP Global Sales, TriLink BioTechnologies

To learn more about TriLink’s new GMP enzyme capabilities visit: https://www.trilinkbiotech.com/gmp-enzymes

About TriLink BioTechnologies

TriLink BioTechnologies, part of Maravai LifeSciences, is a global leader in nucleic acid technologies and manufacturing solutions for RNA therapeutics, vaccines, gene editing, and diagnostics. The company's portfolio includes modified nucleotides, mRNA products, proprietary technologies such as CleanCap® capping analogs and ModTail™ technology, and a growing portfolio of high-performance enzymes marketed under the Alphazyme brand. Supported by robust GMP manufacturing capabilities, TriLink enables customers from early-stage research through commercial production.

About Maravai LifeSciences

Maravai LifeSciences is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world’s leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapies companies.

More News From Maravai LifeSciences

Back to Newsroom

New Sprout Social research reveals social media is the first place consumers hear about brand crises and the first place they expect brands to respond in real time June 18, 2026 09:00 ET  | Source: Sprout Social, Inc

CHICAGO, June 18, 2026 (GLOBE NEWSWIRE) -- According to new research from Sprout Social (NASDAQ: SPT), a leading AI-powered Social Intelligence Platform, social media has become the epicenter of modern brand crises, where controversies are first discovered, public opinion forms, and consumers look for brands to respond. Sprout Social's Q2 2026 Pulse Survey finds that when a brand has a controversial moment, social media is the number one place consumers hear about it first, surpassing news articles, friends and family, and the brands themselves.

Because consumers first encounter brand controversies on social, they expect brands to address the issues publicly there as well. Nearly two-thirds (64%) say it is important for brands to respond publicly on social media rather than through a press release or website statement, signaling that the traditional crisis communications playbook won’t meet the expectations of audiences today.

With crises playing out in real time on social, how quickly an organization responds to a crisis also greatly shapes public perception. In fact, 84% of consumers say a brand's response speed directly affects their view of the crisis. This rapid spread of conversation places increased pressure on brands to deliver swift communication that addresses consumer concerns as they happen.

"Brand crises today begin and unfold on social media," said Scott Morris, Chief Marketing Officer at Sprout Social. "The first signals of a reputational threat often appear online long before they make headlines. Social media gives brands a clear look at how people actually feel in the moment, making it one of the most powerful tools for identifying risk, shaping response strategies, and rebuilding trust. The companies that emerge strongest from a crisis are those that use social insights to act quickly, communicate authentically, and make informed decisions before public perception is set."

Despite heightened scrutiny on social media, consumers are willing to give brands a second chance when issues are handled effectively. In fact, 51% of consumers would consider buying from a brand within a few months of the crisis being properly addressed, with 20% returning within a few days. The findings indicate that how a brand responds during a crisis can directly impact consumer trust and future purchase behavior, making the speed, channel, and message all critical factors in reputation recovery.

Beyond crisis communication, the Q2 2026 Pulse Survey highlights the growing role social plays across the consumer journey:

What consumers search for most on social: Consumers turn to social equally to search for product reviews, travel ideas, and news (all 30%), with restaurants and things to do being most searched (38%).YouTube search spans generations: YouTube is the only platform to rank among the top three search platforms across every generation, from Gen Z to Baby Boomers.Live events go social-first: 80% of consumers watch live events through social media, rising to 93% among Gen Z.'Unhinged' marketing has limits: 47% enjoy bold, humor-driven brand content for fun categories like snacks or gaming, but find it unprofessional for serious industries like banking or tech; 24% love it universally. For more, including consumer data on influencer trust, social search behaviors by generation, and marketing tone preferences, access the full Q2 2026 Pulse Survey here.

About the data

This consumer survey was conducted online by Glimpse, a global market research firm, on behalf of Sprout Social. Participants included 2,250 social media users across the US, UK, and Australia. The survey was conducted from May 14, 2026, to May 20, 2026.

About Sprout Social

Sprout Social is a leading AI-powered Social Intelligence platform, built on the belief that All Business is Social℠. Powered by Trellis, Sprout’s proprietary AI agent, the platform transforms real-time social media signals into actionable insights that drive business forward. Consistently recognized as a top software by G2, Sprout enables brands to deliver smarter, faster business impact through a suite of solutions including comprehensive publishing and engagement, customer care, influencer marketing, advocacy and predictive media intelligence. Sprout’s software operates across all major social networks and digital platforms. For more information about Sprout Social (NASDAQ: SPT), visit sproutsocial.com.

Social Media Profiles
www.x.com/SproutSocial
www.x.com/SproutSocialIR
www.facebook.com/SproutSocialInc
www.linkedin.com/company/sprout-social-inc-/
www.instagram.com/sproutsocial

Media Contact
Kaitlyn Gronek
Email: [email protected]
Phone: (773) 904-9674

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.

Zacks Premium also includes the Zacks Style Scores.

What are the Zacks Style Scores? Developed alongside the Zacks Rank, the Zacks Style Scores are a group of complementary indicators that help investors pick stocks with the best chances of beating the market over the next 30 days.

Each stock is given an alphabetic rating of A, B, C, D or F based on their value, growth, and momentum qualities. With this system, an A is better than a B, a B is better than a C, and so on, meaning the better the score, the better chance the stock will outperform.

The Style Scores are broken down into four categories:

Value ScoreValue investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value. Utilizing ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and many other multiples, the Value Style Score identifies the most attractive and most discounted stocks.

Growth ScoreGrowth investors, on the other hand, are more concerned with a company's financial strength and health, and its future outlook. The Growth Style Score examines things like projected and historic earnings, sales, and cash flow to find stocks that will experience sustainable growth over time.

Momentum ScoreMomentum traders and investors live by the saying "the trend is your friend." This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks.

VGM ScoreIf you want a combination of all three Style Scores, then the VGM Score will be your friend. It rates each stock on their combined weighted styles, helping you find the companies with the most attractive value, best growth forecast, and most promising momentum. It's also one of the best indicators to use with the Zacks Rank.

How Style Scores Work with the Zacks Rank The Zacks Rank is a proprietary stock-rating model that harnesses the power of earnings estimate revisions, or changes to a company's earnings expectations, to help investors build a successful portfolio.

It's highly successful, with #1 (Strong Buy) stocks producing an unmatched +24% average annual return since 1988. That's more than double the S&P 500. But because of the large number of stocks we rate, there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.

But it can feel overwhelming to pick the right stocks for you and your investing goals with over 800 top-rated stocks to choose from.

That's where the Style Scores come in.

You want to make sure you're buying stocks with the highest likelihood of success, and to do that, you'll need to pick stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you like a stock that only has a #3 (Hold) rank, it should also have Scores of A or B to guarantee as much upside potential as possible.

Since the Scores were created to work together with the Zacks Rank, the direction of a stock's earnings estimate revisions should be a key factor when choosing which stocks to buy.

A stock with a #4 (Sell) or #5 (Strong Sell) rating, for instance, even one with Scores of A and B, will still have a declining earnings forecast, and a greater chance its share price will fall too.

Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.

Stock to Watch: Exelixis (EXEL - Free Report) Alameda, CA-based Exelixis, Inc. is an oncology-focused biotechnology company that primarily focuses on the discovery, development and commercialization of new drugs for the treatment of difficult-to-treat cancers. The company is leveraging its investments, expertise and strategic partnerships to target an expanding range of tumor types and indications with its clinically differentiated pipeline of small molecules, antibody-drug conjugates (ADCs) and other biotherapeutics.

EXEL is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.

Momentum investors should take note of this Medical stock. EXEL has a Momentum Style Score of A, and shares are up 5.1% over the past four weeks.

For fiscal 2026, five analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.16 to $3.53 per share. EXEL boasts an average earnings surprise of +17%.

With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, EXEL should be on investors' short list.

Have you been paying attention to shares of Integra LifeSciences (IART - Free Report) ? Shares have been on the move with the stock up 23.7% over the past month. The stock hit a new 52-week high of $18.19 in the previous session. Integra has gained 40.6% since the start of the year compared to the -4.2% move for the Zacks Medical sector and the -16.9% return for the Zacks Medical - Instruments industry.

What's Driving the Outperformance?The stock has a great record of positive earnings surprises, as it hasn't missed our earnings consensus estimate in any of the last four quarters. In its last earnings report on May 5, 2026, Integra reported EPS of $0.54 versus consensus estimate of $0.41 while it beat the consensus revenue estimate by 2.74%.

For the current fiscal year, Integra is expected to post earnings of $2.42 per share on $1.67 in revenues. This represents a 8.52% change in EPS on a 2.24% change in revenues. For the next fiscal year, the company is expected to earn $2.57 per share on $1.73 in revenues. This represents a year-over-year change of 6.3% and 3.27%, respectively.

Valuation MetricsWhile Integra has moved to its 52-week high over the past few weeks, investors need to be asking, what is next for the company? A key aspect of this question is taking a look at valuation metrics in order to determine if the company is due for a pullback from this level.

On this front, we can look at the Zacks Style Scores, as these give investors a variety of ways to comb through stocks (beyond looking at the Zacks Rank of a security). These styles are represented by grades running from A to F in the categories of Value, Growth, and Momentum, while there is a combined VGM Score as well. The idea behind the style scores is to help investors pick the most appropriate Zacks Rank stocks based on their individual investment style.

Integra has a Value Score of B. The stock's Growth and Momentum Scores are B and F, respectively, giving the company a VGM Score of B.

In terms of its value breakdown, the stock currently trades at 7.2X current fiscal year EPS estimates, which is not in-line with the peer industry average of 23.1X. On a trailing cash flow basis, the stock currently trades at 4.1X versus its peer group's average of 13.3X. Additionally, the stock has a PEG ratio of 1.22. This isn't enough to put the company in the top echelon of all stocks we cover from a value perspective.

Zacks RankWe also need to look at the Zacks Rank for the stock, as this is even more important than the company's VGM Score. Fortunately, Integra currently has a Zacks Rank of #2 (Buy) thanks to a solid earnings estimate revision trend.

Since we recommend that investors select stocks carrying Zacks Rank of 1 (Strong Buy) or 2 (Buy) and Style Scores of A or B, it looks as if Integra passes the test. Thus, it seems as though Integra shares could have potential in the weeks and months to come.

-

New product delivers performance benchmarks, portfolio insights, and liquidity forecasts built on validated private markets data

BOISE, Idaho & NEW YORK & CHICAGO & LONDON & HONG KONG--(BUSINESS WIRE)--Clearwater Analytics (NYSE: CWAN) today launched Fund Analytics, a private markets intelligence product built on the same validated investment data foundation that powers institutional accounting and books of record across more than $10 trillion in global assets.

Private markets have become a core allocation for institutional investors, but the infrastructure supporting them remains fragmented and highly manual. Investment teams still extract, validate, and reconcile information from GP reports before they can answer basic questions about performance, exposures, and future capital needs. Because no fund managers report the same way, many analytics platforms are only as reliable as the data that is manually entered into them.

Built on Clearwater's document processing and data validation technology, Fund Analytics structures and validates private markets data before it reaches the analytics layer. The result is a platform where performance measurement, benchmarking, portfolio monitoring, and liquidity forecasting are built on verified investment data rather than spreadsheet-driven workflows and self-reported submissions.

At the center of Fund Analytics is the Fund Master, a dataset built from Clearwater's network of institutional investors investing in many of the same underlying private funds. By validating and standardizing data at scale, Clearwater creates a shared intelligence layer that enables investors to benchmark their investments’ performance, compare valuations, aggregate exposures, and analyze portfolios using insights that no single institution could generate independently.

"Private markets intelligence is only as reliable as the data underneath it," said Kirat Singh, President of Risk and Alternative Assets at Clearwater Analytics. "For years, investors have relied on analytics built on manually collected information. With Fund Analytics, data is validated before it reaches the analytics layer, creating benchmarks, forecasts, and portfolio insights institutions can trust."

Fund Analytics brings together four core capabilities on a single data foundation:

Performance Analytics and Benchmarking
Measure performance across funds, co-investments, and portfolios using standardized metrics and benchmarks derived from Clearwater's validated Fund Master dataset.

Portfolio Monitoring and Look-Through Analysis
See exactly what is inside every fund, from underlying portfolio companies and sector concentrations to geographic exposures and investment themes, with a Data Quality score for every underlying asset.

Liquidity Forecasting
Model future capital calls, distributions, and cash flows with confidence, supporting portfolio construction, pacing, and capital deployment decisions.

Document Processing and Data Validation
Eliminate manual GP report processing. Automatically extract, standardize, and validate information from fund statements, so investment teams spend less time reconciling information and more time acting on it.

Unlike traditional private markets analytics solutions that rely primarily on data submitted by individual firms, Fund Analytics combines validated investment data, network-scale benchmarks, and portfolio intelligence within a single platform. The result is a more complete view of private markets performance, risk, and future liquidity needs.

"Private markets investors don't need more data. They need confidence in the data behind every decision," added Kirat Singh. "Fund Analytics brings together validated data, analytics, and benchmarks in a way that helps institutions move from collecting information to acting on it."

Fund Analytics can be deployed alongside existing accounting infrastructure, extending Clearwater's private markets capabilities to more than 10,000 investors globally, managing $500 million or more in private markets assets.

Learn more about Fund Analytics and register for the upcoming product webinar today.

About Clearwater Analytics

Clearwater Analytics is transforming investment management with the industry’s most comprehensive cloud-native platform for institutional investors across global public and private markets. While legacy systems create risk, inefficiency, and data fragmentation, Clearwater’s single-instance, multi-tenant architecture delivers real-time data and AI-driven insights throughout the investment lifecycle. The platform eliminates information silos by integrating portfolio management, trading, investment accounting, reconciliation, regulatory reporting, performance, compliance, and risk analytics in one unified system. Serving leading insurers, asset managers, hedge funds, banks, corporations, and governments, Clearwater supports over $10 trillion in assets globally. Learn more at www.cwan.com.

More News From Clearwater Analytics

Back to Newsroom

June 17, 2026 16:29 ET  | Source: Legend Biotech USA Inc.

BRIDGEWATER, N.J., June 17, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech” or the “Company”), a global leader in cell therapy, today announced that it has commenced an underwritten public offering of $225 million of American Depositary Shares (“ADSs”), each representing two ordinary shares of the Company. All of the ADSs will be offered by Legend Biotech. Legend Biotech also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the ADSs sold in the public offering at the public offering price, less underwriting discounts and commissions. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed or the actual size or terms of the offering.

Morgan Stanley, Jefferies, Citigroup, and Deutsche Bank Securities are serving as joint book-running managers for the offering.

The ADSs are being offered by Legend Biotech pursuant to an effective shelf registration statement that was previously filed with the Securities and Exchange Commission (“SEC”). The offering is being made only by means of a written prospectus and prospectus supplement that form a part of the registration statement. A preliminary prospectus supplement and accompanying prospectus relating to and describing the terms of the offering will be filed with the SEC and will be available on the SEC’s website at www.sec.gov. A copy of the preliminary prospectus supplement and the accompanying prospectus can be obtained, when available, from Morgan Stanley Asia Limited, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014, email: [email protected]; Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, New York, NY 10022, by telephone: (877) 821-7388, or by email: [email protected]; Citigroup, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by telephone: (800) 831-9146; or Deutsche Bank Securities Inc., Attention: Prospectus Group, 1 Columbus Circle, New York, NY 10019, by telephone: (800) 503-4611, or by email: [email protected].

This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities being offered, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Legend Biotech
With over 3,000 employees, Legend Biotech is the largest standalone cell therapy company and a pioneer in treatments that change cancer care forever. Legend Biotech is at the forefront of the CAR-T cell therapy revolution with CARVYKTI®, a one-time treatment for relapsed or refractory multiple myeloma, which it develops and markets with collaborator Johnson & Johnson. Centered in the United States, Legend Biotech is building an end-to-end cell therapy company by expanding its leadership to maximize CARVYKTI’s patient access and therapeutic potential. From this platform, Legend Biotech plans to drive future innovation across its pipeline of cutting-edge cell therapy modalities.

Cautionary Note Regarding Forward-Looking Statements
Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute “forward-looking statements” within the meaning of The Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to the proposed public offering. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: the uncertainties related to market conditions and the completion of the proposed public offering on the anticipated terms or at all, the Company’s intent to grant the underwriters a 30-day option to purchase additional ADSs in the proposed public offering, and the other factors discussed in the “Risk Factors” section of Legend Biotech’s Annual Report on Form 20-F for the year ended December 31, 2025 filed with the SEC on March 10, 2026, as well as in Legend Biotech’s other filings with the SEC. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in this press release as anticipated, believed, estimated or expected. Any forward-looking statements contained in this press release speak only as of the date hereof, and Legend Biotech specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. Readers should not rely upon the information in this press release as current or accurate after its publication date.

INVESTOR CONTACT:
Jessie Yeung
Tel: (732) 956-8271
[email protected]

PRESS CONTACT:
Kim Fox
Tel: (848) 388-8445
[email protected]

U.S. stock futures were higher this morning, with the Nasdaq futures gaining over 1% on Thursday.

Shares of Legend Biotech Corp (NASDAQ:LEGN) fell sharply in pre-market trading after the company announced the pricing of public offering.

Legend Biotech priced a public offering of 7.7 million ADSs at $29.35 per ADS, raising gross proceeds of $226 million.

Legend Biotech shares dipped 9% to $30.50 in pre-market trading.

Here are some other stocks moving lower in pre-market trading.

Photo via Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

The $250 million contract is the single largest tracked defense order in Allison's history

, /PRNewswire/ -- Allison Transmission Holdings, Inc. (NYSE: ALSN), a global leader in high-performance mobility and work solutions, today announced that it has entered into a contract with BAE Systems Hägglunds to supply 4040 MX™ transmissions for the company's CV90 MkIV infantry fighting vehicles. The $250 million agreement, formalized today at the Eurosatory defense exhibition in Paris, includes an option for additional units valued at $50 million. The agreement is the largest single tracked defense program contract in Allison Transmission's history.

Allison Transmission will supply its 4040 MX™ transmissions for BAE Systems Hägglunds CV90 MkIV vehicles, pictured above.

Tommy Gustafsson-Rask, President at BAE Systems Hägglunds, Dave Graziosi, Chair, President and CEO of Allison, and Dana Pittard, Vice President of Defense Programs at Allison Transmission at the Eurosatory defense exhibition.

Tommy Gustafsson-Rask, President at BAE Systems Hägglunds, and Dana Pittard, Vice President of Defense Programs at Allison Transmission, sign the agreement at Eurosatory. The CV90 MkIV program serves as the inaugural production platform for Allison's 4040 MX transmission, and production deliveries are scheduled to begin in 2028. Engineered as an evolution of the proven 3040 MX, the new 4040 MX cross-drive transmission delivers increased power ratings and updated electronic controls while maintaining the existing 3040 MX spatial footprint, allowing for seamless integration with the vehicle's Scania engine. Allison conducted extensive integration testing with BAE Systems Hägglunds over a two-year period to ensure the new solution is mission ready.

"The integration and selection of Allison's 4040 MX cross-drive transmission into the CV90 MkIV is a critical milestone in delivering increased mobility and performance," said Tommy Gustafsson-Rask, President at BAE Systems Hägglunds. "This contract highlights our mutual commitment to providing robust solutions that meet the evolving operational requirements of the armed forces."

"This historic agreement underscores the proven reliability of Allison's propulsion solutions in the most demanding environments and missions," said Dana Pittard, Vice President of Defense Programs at Allison Transmission. "By working with BAE Systems Hägglunds, we are delivering a propulsion solution that not only meets the rigorous demands of modern combat vehicles but also demonstrates our collective readiness to support national security initiatives around the world."

About Allison Transmission  
Allison Transmission Holdings, Inc. (NYSE: ALSN) ("Allison") is a global leader in high-performance mobility and work solutions built for the needs of the modern industrial world. Allison operates through two business units: Allison Transmission and Allison Off-Highway Drive & Motion Systems. Headquartered in Indianapolis, Indiana, USA, the Company manufactures solutions which offer industry-leading value propositions across vital sectors such as infrastructure, mining, energy, agriculture, construction, transportation and national security. For over 110 years, Allison has been recognized as a reliable partner of choice, keeping essential industries moving anytime, in over 150 countries around the world. For more information, visit https://allisontransmission.com

Forward-Looking Statements
This press release contains forward-looking statements. The words "believe," "expect," "anticipate," "intend," "estimate" and other expressions that are predictions of or indicate future events and trends and that do not relate to historical matters identify forward-looking statements. You should not place undue reliance on these forward-looking statements. Although forward-looking statements reflect management's good faith beliefs, reliance should not be placed on forward-looking statements because they involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from anticipated future results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements speak only as of the date the statements are made. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, changed circumstances or otherwise. These forward-looking statements are subject to numerous risks and uncertainties, including, but not limited to: the significant costs we are expected to incur in connection with the integration of the Off-Highway Drive & Motion Systems business of Dana Incorporated (now referred to as the "Allison Off-Highway Business"); our ability to successfully integrate the Allison Off-Highway Business and its operations in the expected time frame; our ability to realize all of the anticipated benefits from the integration of the Allison Off-Highway Business and its operations and to effectively manage our expanded operations; our participation in markets that are competitive; our ability to prepare for, respond to and successfully achieve our objectives relating to technological and market developments, competitive threats and changing customer needs, including with respect to electric hybrid and fully electric commercial vehicles; increases in cost, disruption of supply or shortage of labor, freight, raw materials, energy or components used to manufacture or transport our products or those of our customers or suppliers, including as a result of geopolitical risks, natural disasters, extreme weather events, wars and public health crises such as pandemics; global economic volatility; general economic and industry conditions, including the risk of prolonged inflation and recession; labor strikes, work stoppages or similar labor disputes, which could significantly disrupt our operations or those of our principal customers or suppliers; the highly cyclical industries in which certain of our end users operate; uncertainty in the global regulatory and business environments in which we operate; the concentration of our net sales in our top five customers and the loss of any one of these customers; cybersecurity risks to our operational systems, security systems or infrastructure owned by us or our third-party vendors and suppliers; the failure of markets outside North America to increase adoption of fully automatic transmissions; the success of our research and development efforts, the outcome of which is uncertain; U.S. and foreign defense spending; risks associated with our international operations, including acts of war and increased trade protectionism and tariffs; the discovery of defects in our products, resulting in delays in new model launches, recall campaigns and/or increased warranty costs and reduction in future sales or damage to our brand and reputation; our ability to identify, consummate and effectively integrate acquisitions and collaborations; and risks related to our indebtedness.

SOURCE Allison Transmission, Inc.